Navigation Links
De Vilbiss Cranial Rongeur

ProductsDe Vilbiss Cranial Rongeur
Company Codman
Item De Vilbiss Cranial Rongeur
Features 
Description 
Info Codman
Customer Service: (800) 225-0460
Web site: http://www.codman.com

Related medicine products :

1. DeVilbiss Pulmo-Aide® Compact Compressor/Nebulizer With Reusable Neb
2. DeVilbiss Pulmo-Aide® Compact Compressor/Nebulizer With Disposable Neb
3. Adson Cranial Rongeur
4. Bacon Cranial Rongeur
5. Instatrak - Cranial
6. Neuroclip Cranial Flap Fixation System
7. TEW Cranial/Spinal Retractor (A 1090)
8. Stookey Cranial Rongeur
9. Marchac Cranial Rongeur
10. Cranial Drill
11. Hudson Cranial Drill
The Mago® Plus Automated EIA Analyzer is a fully automated, integrated ELISA system. Together, with immunosimplicity® reagents, the Mago® Plus provides a flexible, integrated solution
The LABOTECH is an automated microplate analyzer capable of fully automating immunoenzymatic microplate techniques. Open architecture design makes the system adaptable to many manufacturers' micropla
The Titertek MAP-C2 is designed for high throughput microplate processing. The heart of the instrument is the S60 Stacker that handles up to 60 microplates in two removable magazines. The MAP-C2 base
The Rapidpoint 400/405 instrument is a point-of-care blood gas analyzer that's fast, easy to operate and reliable.
Medicine Products:
(Date:11/21/2008)... Conney Safety,s New Website is Simple, Powerfu...ping for Safety Products Easier than Ever , ..., 2008 -- Conney Safety Products is proud to annou... has been completely redesigned using state-of-the...fficient and features a clean new layout to make s...
(Date:11/20/2008)...ng is everything, and that certainly appears to be...ur months before the height of cold and flu season...a than children born at any other time of year, ac...he birth and medical records of more than 95,000 c...e whether date of birth in relationship to the pea...
(Date:11/20/2008)... NOVEMBER 2008 The consumption of illicit or nonc...worldwide and contributes significantly to the glo...eleased today by the International Center for Alco... of noncommercial alcohol, defined as traditional ... local trade and counterfeit or unregistered produ...
(Date:11/20/2008)...g could be key to new disease-fighting therapies ,... New research on mice suggests inhibiting a protei...ove to be key to cancer-fighting treatments. , ...rsite catholique de Louvain, in Belgium, found tha... on whether they are in regions rich in oxygen or ...
Breaking Medicine News(10 mins):Health News:Conney Safety Products, Leader in Safety Equipment and Supplies, Launches New Website 2Health News:Fall babies: Born to wheeze? 2Health News:Report finds extensive use of illicit alcohol 2
... rich source of live-saving stem cells, seven bank...ia, and the first of the series will open in Gurga...between Cryobanks International, a US body, and R.... Ravi Jaipuria, will invest Rs.1 billion to build ...
... study has discovered a connection between genetic...cies play a significant role in the use of drugs./...rch, said "This is the first study to show the im...re/country (Norway) with rather low rates of drug ...
... trouble falling or staying asleep, you're not alo...rly seven out of 10 Americans say they frequently/...that may be cause for concern, says Henry Raroque,...p specialist on the medical staff at Baylor Region...
...rnment has planned to outlaw sex selection of babi... of embryology regulation.// Health Minister Caro...o introduce a "clear and specific ban" on the use ...by, saying that allowing such practices among pare...
Other Medicine News:Health News:First Cord Blood Bank in North India to be Opened in Gurgaon 2
(Date:11/19/2008)...re-FirstCall/ -- Amgen,(Nasdaq: AMGN ) and Mill...of,Takeda Pharmaceutical Company Limited (TSE: 40... 3 MONET1 trial evaluating motesanib (AMG 706) in,...he first-line treatment of,advanced non-small cel...ed,following a planned safety data review of 600 ...
(Date:11/19/2008)... -- Biotech scientists increasingly are applying g...ter understand the effects of novel drug candidate...Engineering & Biotechnology News ( GEN ). The...compound,s mechanism of action and eventually deve...g to the November 15 issue of GEN . ( http://www....
(Date:11/18/2008)...l/ -- NeuroDiscovery Ltd (ASX:,NDL), a specialty ... Company,and Sosei Group Corporation ("Sosei"; T...biopharmaceutical company, today announce that Neu...nical efficacy data for NSL-043/SD118.,This inves...thic pain and has,successfully completed Phase I ...
(Date:11/18/2008)...wswire/ -- Forty-two leading U. S. scientists and ...to consider cutting-edge innovations that may defe...om outbreaks of dangerous zoonotic diseases, the F... innovations: , , , , A "Doc in...ts highly contagious and dangerous zoonotic diseas...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine 5572 1Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine 5572 2Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine 5572 3Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine 5572 4Oregano oil works as well as synthetic insecticides to tackle common beetle pest 3395 1DolmatConnell 26 Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Im 5568 1DolmatConnell 26 Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Im 5568 2DolmatConnell 26 Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Im 5568 3CAPHOSOL 28R 29 Relieves Oral Mucositis 28OM 29 and Improves Quality of Life in Cancer Patients Receiving Chemoradiation 2168 1CAPHOSOL 28R 29 Relieves Oral Mucositis 28OM 29 and Improves Quality of Life in Cancer Patients Receiving Chemoradiation 2168 2CAPHOSOL 28R 29 Relieves Oral Mucositis 28OM 29 and Improves Quality of Life in Cancer Patients Receiving Chemoradiation 2168 3CAPHOSOL 28R 29 Relieves Oral Mucositis 28OM 29 and Improves Quality of Life in Cancer Patients Receiving Chemoradiation 2168 4CAPHOSOL 28R 29 Relieves Oral Mucositis 28OM 29 and Improves Quality of Life in Cancer Patients Receiving Chemoradiation 2168 5CAPHOSOL 28R 29 Relieves Oral Mucositis 28OM 29 and Improves Quality of Life in Cancer Patients Receiving Chemoradiation 2168 6
... Pending Final Analysis of the Results, ISTA Plans...-, IRVINE, Calif., May 31, 2007 /PRNewswire-FirstC...ed positive results from the,preliminary analysis ...t sodium, which is being developed as a treatment ...m group achieved a strong,trend in the objective s...
...CALGARY, June 01, 2007 /PRNewswire-FirstCall/ - Re...("Oncolytics") are,scheduled to deliver a poster p...ta at the American Society of Clinical Oncology,(A...Chicago. The,data cover final results of Oncolytic...he poster, entitled "Final Results of a Phase I St...
Other Medicine Technology:ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 2ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 3ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 5Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference 2